Mark Krailo

Also affiliated with University of California, Los Angeles, Children's Oncology Group

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group”.

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of Clinical Oncology(2023)10.1200/jco.22.01815

N/A

1.7DataRank · unranked

89 citations

Mark Krailo, Julia Glade Bender, Allen Buxton, Nadia N. Laack, R. Lor Randall +20 more

Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group

Journal of Clinical Oncology(2023)10.1200/jco.22.01777

N/A

0.507DataRank · unranked

10 citations

Gilbert Vézina, Mark Krailo, Linda Springer, Allen Buxton, Cody J. Peer +7 more

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9014

N/A

0.373DataRank · unranked

11 citations

Mark Krailo, Sukhmani K. Padda, Susan Groshen, Heather A. Wakelee, Karen L. Reckamp +14 more

The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research

The Lancet Oncology(2021)10.1016/s1470-2045(21)00077-2

N/A

0DataRank · unranked

42 citations

Girish Chinnaswamy, Manju Sengar, Durga Gadgil, Shivakumar Thiagarajan, Balram Bhargava +22 more

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.08.006

N/A

0DataRank · unranked

35 citations

John T. Lafin, Cinzia G. Scarpini, Michelle M. Nuño, Isabella Syring, Klaus‐Peter Dieckmann +9 more

Updated outcomes for patients with completely resected pulmonary recurrent osteosarcoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10023

N/A

0DataRank · unranked

3 citations

Mark Krailo, Ruxu Han, Allen Buxton, Damon R. Reed, Richard Görlick +5 more

Explicit underdose control based on toxicity: Four points to consider

Statistics in Medicine(2022)10.1002/sim.9492

N/A

0DataRank · unranked

1 citations

Elizabeth Garrett‐Mayer, Mark Krailo, Paul Frankel

Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children’s Oncology Group study AEWS0031.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11505

N/A

0DataRank · unranked

6 citations

Mark Krailo, Allen Buxton, Bruce Pawel, John H. Healey, Odion Binitie +10 more

Children's Oncology Group's 2023 blueprint for research: Bone tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30583

N/A

0DataRank · unranked

19 citations

Patrick J. Grohar, Elyssa Rubin, Odion Binitie, Mark Krailo, Jessica L. Davis +3 more

Special considerations in the design and implementation of pediatric otoprotection trials

Journal of Cancer Survivorship(2023)10.1007/s11764-022-01312-x

N/A

0DataRank · unranked

17 citations

Etan Orgel, Kristin R. Knight, Mark Krailo, David R. Freyer

Reevaluation of sodium thiosulfate otoprotection using the consensus International Society of Paediatric Oncology Ototoxicity Scale: A report from the Children's Oncology Group study ACCL0431

Pediatric Blood & Cancer(2023)10.1002/pbc.30550

N/A

0DataRank · unranked

9 citations

Kristin R. Knight, Doojduen Villaluna, Mark Krailo, Adam J. Esbenshade, Lillian Sung +2 more

AGCT1531: Evaluating the utility of circulating microRNA in the management of children, adolescents, and adults with malignant germ cell tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5104

N/A

0DataRank · unranked

3 citations

Aditya Bagrodia, James F. Amatruda, Michelle M. Nuño, Matthew J. Murray, Nicholas Coleman +8 more

Evaluation of local control strategies on patterns of treatment failure in patients with localized ewing sarcoma treated on AEWS1031: A report from the children’s oncology group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11529

N/A

0DataRank · unranked

2 citations

Odion Binitie, Mark Krailo, Allen Buxton, Daniel J. Indelicato, Alexandra K. Callan +12 more

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7063

N/A

0DataRank · unranked

9 citations

Alyaa Al‐Ibraheemi, Jessica L. Davis, C. Matthew Hawkins, Brian T. Craig, Roshni Dasgupta +26 more

Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae103

N/A

0DataRank · unranked

6 citations

Ruxu Han, Mark Krailo, David S. Shulman, Brent R. Weil, Christopher B. Weldon +12 more

Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.31820

N/A

0DataRank · unranked

5 citations

Alexandra K. Callan, Safia K. Ahmed, Mark Krailo, Natalie DelRocco, Allen Buxton +14 more

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf083

N/A

0DataRank · unranked

4 citations

Kathleen Montgomery, Adam DuVall, Michael Roth, Mark Krailo, Michelle M. Nuño +13 more

Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children’s Oncology Group

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.11.010

N/A

0DataRank · unranked

1 citations

Odion Binitie, Mark Krailo, Daniel J. Indelicato, Alexandra K. Callan, Natalie DelRocco +14 more

Outcome of Children With Intermediate‐Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.32033

N/A

0DataRank · unranked

0 citations

Doojduen Villaluna, Mark Krailo, Thomas A. Olson, Farzana Pashankar, Marcio H. Malogolowkin +9 more

A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)

Pediatric Blood & Cancer(2020)10.1002/pbc.28502

N/A

0DataRank · unranked

16 citations

Judith G. Villablanca, Mark Krailo, Jin Piao, Li Huang, A. Linn Murphree +6 more

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885

N/A

0DataRank · unranked

0 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more

Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10508

N/A

0DataRank · unranked

18 citations

Mark Krailo, Allen Buxton, Paul R. Hutson, J. Wade Davis, Katherine A. Janeway +3 more

Maximum tumor dimension and tumor volume as prognostic factors in patients with newly diagnosed localized Ewing sarcoma (ES)- a report from the Children’s Oncology Group (COG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11529

N/A

0DataRank · unranked

4 citations

Allen Buxton, Steven G. DuBois, Dian Wang, Nadia N. Laack, Kenneth L. Brown +15 more